SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010563
Filing Date
2021-08-05
Accepted
2021-08-05 16:19:28
Documents
80
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20210630x10q.htm   iXBRL 10-Q 2627289
2 EX-31.1 chrs-20210630xex31d1.htm EX-31.1 13743
3 EX-31.2 chrs-20210630xex31d2.htm EX-31.2 14629
4 EX-32.1 chrs-20210630xex32d1.htm EX-32.1 12450
  Complete submission text file 0001558370-21-010563.txt   10097757

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20210630.xsd EX-101.SCH 64496
6 EX-101.CAL chrs-20210630_cal.xml EX-101.CAL 77601
7 EX-101.DEF chrs-20210630_def.xml EX-101.DEF 317877
8 EX-101.LAB chrs-20210630_lab.xml EX-101.LAB 536316
9 EX-101.PRE chrs-20210630_pre.xml EX-101.PRE 464494
10 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20210630x10q_htm.xml XML 1959772
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 211148492
SIC: 2836 Biological Products, (No Diagnostic Substances)